Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1979 1
1985 1
1986 1
1988 1
1989 1
1990 1
1992 1
1994 2
1997 1
1998 1
1999 1
2000 2
2002 3
2003 2
2005 4
2006 1
2007 3
2008 2
2009 1
2011 3
2012 1
2013 4
2014 3
2016 1
2017 2
2018 4
2020 3
2021 1
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Conjunctival Sarcoma"
Page 1
Uses of eye drops in dermatology, literature review.
Sarsik SM, El-Amawy HS. Sarsik SM, et al. J Dermatolog Treat. 2022 Sep;33(6):2758-2770. doi: 10.1080/09546634.2022.2079598. Epub 2022 Jun 2. J Dermatolog Treat. 2022. PMID: 35652324 Review.
The FDA-approved and off-label applications of various eye drops used as topical treatments in dermatological clinical practice were highlighted in this review.Methodology: A thorough PubMed and Google Scholar library search using various combinations of the keywords (Eye …
The FDA-approved and off-label applications of various eye drops used as topical treatments in dermatological clinical practice were …
Targeted Therapy and Immunotherapy for Advanced Malignant Conjunctival Tumors: Systematic Review.
Serbest Ceylanoglu K, Guneri Beser B, Singalavanija T, Juntipwong S, Worden FP, Demirci H. Serbest Ceylanoglu K, et al. Ophthalmic Plast Reconstr Surg. 2024 Jan-Feb 01;40(1):18-29. doi: 10.1097/IOP.0000000000002488. Epub 2024 Jan 18. Ophthalmic Plast Reconstr Surg. 2024. PMID: 38241616 Review.
PURPOSE: To review the outcomes of targeted therapy and immunotherapy in advanced conjunctival tumors, including conjunctival squamous cell carcinoma, conjunctival melanoma, and conjunctival lymphoma. ...CONCLUSIONS: Despite limited clinical cas …
PURPOSE: To review the outcomes of targeted therapy and immunotherapy in advanced conjunctival tumors, including conjunctival …
Neoadjuvant Immune Checkpoint Inhibition in Metastatic Conjunctival Melanoma.
Fan K, Waninger JJ, Yentz S, McLean S, Demirci H. Fan K, et al. Ophthalmic Plast Reconstr Surg. 2023 Sep-Oct 01;39(5):e152-e155. doi: 10.1097/IOP.0000000000002407. Epub 2023 May 16. Ophthalmic Plast Reconstr Surg. 2023. PMID: 37207285
The development of immune checkpoint inhibitors (ICI) has transformed the treatment of advanced-stage cutaneous melanoma; however, most trials did not include patients with conjunctival melanoma. Herein the authors describe a patient with recurrent conjunctival mela …
The development of immune checkpoint inhibitors (ICI) has transformed the treatment of advanced-stage cutaneous melanoma; however, most tria …
The epidemiology of acquired immunodeficiency syndrome malignancies.
Goedert JJ. Goedert JJ. Semin Oncol. 2000 Aug;27(4):390-401. Semin Oncol. 2000. PMID: 10950365 Review.
The acquired immunodeficiency syndrome (AIDS) results in an extraordinary increase in the risk of two malignancies: Kaposi's sarcoma (KS; relative risk [RR], >10,000) and B-cell non-Hodgkin's lymphoma (NHL; RR, >100). ...
The acquired immunodeficiency syndrome (AIDS) results in an extraordinary increase in the risk of two malignancies: Kaposi's sarcoma …
Conjunctival papillomatous lesion.
Adamopoulou C, Rotberg L, Baker JD. Adamopoulou C, et al. JAMA Ophthalmol. 2014 Dec;132(12):1481-2. doi: 10.1001/jamaophthalmol.2014.3883. JAMA Ophthalmol. 2014. PMID: 25501399 No abstract available.
Ocular surface neoplasias and human immunodeficiency virus infection.
Weinstein JE, Karp CL. Weinstein JE, et al. Curr Opin Infect Dis. 2013 Feb;26(1):58-65. doi: 10.1097/QCO.0b013e32835b5969. Curr Opin Infect Dis. 2013. PMID: 23188212 Review.
Conjunctival lymphoma can be recognized with the salmon patch appearance. ...SUMMARY: Ocular surface malignancy manifests significantly in the HIV population. OSSN, Kaposi's sarcoma and conjuctival lymphoma all have different clinical presentations. ...
Conjunctival lymphoma can be recognized with the salmon patch appearance. ...SUMMARY: Ocular surface malignancy manifests significant …
Human immunodeficiency virus-associated giant conjunctival Kaposi's sarcoma: complete remission with antiretroviral therapy and systemic chemotherapy.
Eduardo-Sánchez YW, Fernández-Agrafojo D. Eduardo-Sánchez YW, et al. Arch Soc Esp Oftalmol (Engl Ed). 2018 Jun;93(6):310-312. doi: 10.1016/j.oftal.2017.07.010. Epub 2017 Sep 5. Arch Soc Esp Oftalmol (Engl Ed). 2018. PMID: 28886932 English, Spanish.
Cutaneous, gastric mucosal and conjunctival biopsy was consistent with Kaposi's sarcoma with complete remission after highly active antiretroviral therapy and systemic chemotherapy. CONCLUSION: HIV-related conjunctival Kaposi's sarcoma, even a large on …
Cutaneous, gastric mucosal and conjunctival biopsy was consistent with Kaposi's sarcoma with complete remission after highly a …
Case report of ocular Kaposi's sarcoma.
Yang J, Yin XF, Li YP, Zhou SY. Yang J, et al. BMC Ophthalmol. 2017 Aug 14;17(1):143. doi: 10.1186/s12886-017-0525-0. BMC Ophthalmol. 2017. PMID: 28806949 Free PMC article.
Crit Rev Oncol Hematol 53(3):253-65, 2005; Mbulaiteye and Engels, Int J Cancer 119(11):2685-91, 2006; Tessari et al., Eur J Dermatol 16(5):553-7, 2006). Several Kaposi's sarcoma case reports involving eyelids and conjunctiva have been published (Bavishi et al., Int …
Crit Rev Oncol Hematol 53(3):253-65, 2005; Mbulaiteye and Engels, Int J Cancer 119(11):2685-91, 2006; Tessari et al., Eur J Dermatol 16(5):5 …
Radiation therapy of acquired immunodeficiency syndrome-related Kaposi's sarcoma of the eyelids and conjunctiva.
Ghabrial R, Quivey JM, Dunn JP Jr, Char DH. Ghabrial R, et al. Arch Ophthalmol. 1992 Oct;110(10):1423-6. doi: 10.1001/archopht.1992.01080220085027. Arch Ophthalmol. 1992. PMID: 1417543
We retrospectively studied 42 men with acquired immunodeficiency syndrome-related Kaposi's sarcoma of the conjunctiva or eyelids who were treated with radiation. Forty-nine sites were treated, 35 (71%) of which involved the eyelids, 12 (24%) the conjunctiva, …
We retrospectively studied 42 men with acquired immunodeficiency syndrome-related Kaposi's sarcoma of the conjunctiva or eyeli …
A case report on concurrent occurrence of systemic mastocytosis and myeloid sarcoma presenting with extensive skin involvements and the results of genetic study.
Wang X, Zhang L, Zhou D, Cai H, Wang X, Jiang X. Wang X, et al. Medicine (Baltimore). 2020 Dec 11;99(50):e21948. doi: 10.1097/MD.0000000000021948. Medicine (Baltimore). 2020. PMID: 33327223 Free PMC article.
The most common mutation associated with both systemic mastocytosis and myeloid sarcoma is mutation in Kit. Here, we identified the novel KIT D816V and ARID1A G1254S mutations co-occurring in systemic mastocytosis with myeloid sarcoma. ...MPO, CD117, CD68 positive c …
The most common mutation associated with both systemic mastocytosis and myeloid sarcoma is mutation in Kit. Here, we identified the n …
52 results